Turn Any Smartphone Into a Cloud Mining Tool: Discover The New App For XRP Mining XRP Mining is proud to introduce its latest innovation–a user-focused cloud mining application that enables users worldwide to take part in cryptocurrency mining without any technical expertise. The app is crafted to eliminate the traditional barriers of crypto mining, such […]
Kumar Mangalam Birla, Chairman, Aditya Birla Group Joins the USISPF Executive Committee and Board of Directors GlobeNewswire July 11, 2025 Washington, DC , July 11, 2025 (GLOBE NEWSWIRE) — The U.S.-India Strategic Partnership Forum (USISPF) is proud to announce the appointment of Mr. Kumar Mangalam Birla, Chairman of the Aditya Birla Group, to the USISPF
Hims & Hers Health, Inc. (HIMS) Faces Securities Class Actions After Novo Nordisk Cancels Partnership Over “Deceptive” Marketing of Wegovy- Hagens Berman HIMS Investors with Losses Encouraged to Contact Hagens Berman GlobeNewswire July 11, 2025 SAN FRANCISCO, July 11, 2025 (GLOBE NEWSWIRE) — On June 25, 2025, two securities class action lawsuits were filed against
(NASDAQ:RCKT), SAN FRANCISCO, July 11, 2025 (GLOBE NEWSWIRE) — A securities class action lawsuit styled Ho v. Rocket Pharmaceuticals, Inc., et al., No. 3:25-cv-10049 (D. N.J.) has been filed and seeks to represent investors who purchased or otherwise acquired Rocket Pharmaceuticals securities between February 27, 2025 and May 26, 2025. The lawsuit comes after investors
Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA's Clinical Hold on Gene Therapy Trial – Hagens Berman GlobeNewswire July 11, 2025 SAN FRANCISCO, July 11, 2025 (GLOBE NEWSWIRE) — A securities class action lawsuit styled Ho v. Rocket Pharmaceuticals, Inc., et al., No. 3:25-cv-10049 (D. N.J.) has been filed and
NEW YORK, NY / ACCESS Newswire / July 11, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=156342&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / July 11, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=156343&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
(NYSE:HIMS), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hims To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Hims between April 29, 2025 and June 22, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health GlobeNewswire July 11, 2025 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hims To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Hims between
(TSX-V:RKV),(Boerse Frankfurt – Freiverkehr:7JO0), VANCOUVER, British Columbia, July 11, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next-generation cancer therapies through AI-powered drug discovery proudly congratulates partner, Variational AI, on being honored as the 2025 Emerging Company of the Year – Biotech by Life Sciences BC. This